Discontinued — last reported Q3 '22
Investing
Acquisitions
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ3 2022
How to read this metric
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
Detailed definition
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Peer comparison
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
Metric ID:
cf_acquisitionsHistorical Data
5 periods
| Q2 '21 | Q2 '22 | Q2 '23 | Q2 '24 | Q2 '25 | |
|---|---|---|---|---|---|
| Value | $1.00M | $1.00M | $0.00 | $0.00 | $3.36B |
| QoQ Change | — | +0.0% | -100.0% | — | — |
| YoY Change | — | +0.0% | -100.0% | — | — |
Range$0.00 – $3.36B
CAGR>999%
Avg YoY Growth-50.0%
Median YoY Growth-50.0%
Acquisitions at Other Companies
Frequently Asked Questions
- What is McKesson's acquisitions?
- McKesson (MCK) reported acquisitions of $3.36B in Q2 2025.
- What does acquisitions mean?
- Cash spent to acquire other companies or businesses, net of cash received in the deal.